VJHemOnc Podcast

VJHemOnc Podcast

VJHemOnc

447 - Hodgkin lymphoma in 2026: frontline strategies, ctDNA, and treatment after relapse
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com
447 - Hodgkin lymphoma in 2026: frontline strategies, ctDNA, and treatment after relapse
00:00
00:00
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com

Episodios

447-

Hodgkin lymphoma in 2026: frontline strategies, ctDNA, and treatment after relapse

10 jul. 2026
446-

Sequencing BTK inhibitor therapy in CLL: treatment considerations and emerging strategies

30 jun. 2026
445-

Precision medicine in AML: from targeted therapy to transplantation

22 jun. 2026
444-

MPNs in focus: disease progression, risk assessment, and emerging treatments

15 jun. 2026
443-

The evolving role of cellular therapies and T-cell engagers in lymphoma

29 mayo 2026